Porokeratosis treatment market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

  • Single User License $3500

Porokeratosis treatment market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

Status : May, 2021 | Healthcare IT

Report Digest


Porokeratosis is a rare skin disorder which may develop skin cancer in adverse case resulting from abnormal clonal expansion of keratinocytes. The disease is majorly associated with immunosuppression, ultra violet radiation, systematic, infectious and neoplastic diseases. The disease usually occurs on a sun exposed skin mostly and is prevalent among people above 50 years of age. Ultraviolet light, harmful to skin is the major cause of prevailing porokeratosis. The most common types of porokeratosis are PM and DSAP which tend to be on your arms or legs.    

Oral and topical retinoids, fluorouracil cream, diclofenac gel, vitamin D3, imiquimod cream, surgical operations such as excision, cryotherapy, laser therapy are some of the treatments for porokeratosis. However, all the treatments may take some time to cure the problem completely.

Laser Therapy as a Treatment for Porokeratosis to have a Lucrative Growth

Laser therapy has been increasingly used for the treatment of porokeratosis. The doctor destroys the patch of skin with a laser device which allows new skin to appear. As per an article by Amarateedha Prak LeCourt, laser therapies were performed on different patients suffering from different types of porokeratosis and the results were wholesome. For instance, one patient with linear porokeratosis showed improvement when 585 nm flashlamp-pumped pulsed eye laser. The laser therapy went successful on another patient with DSAP. As laser therapy is safe and having no downtime or morbidity associated with pigment or textual changes, its adoption may fuel the growth in porokeratosis treatment.     

Growing Prevalence of Disseminated Superficial Actinic Porokeratosis

DSAP is a type of porokeratosis mainly on the fore-arms and legs due to excess sun exposure. Its development in women is twice as compared to men of 30-50 years of age and almost 43.4% incidences of DSAP are reported. DSAP is generally harmless but in adverse cases there is a risk of developing squamous cell carcinomas at the affected area of the body. There are several creams and gels for preventing the infection, thus growing the adoption of treatments market. It is a rare disease and almost 200,000 people are affected with DSAP in US. According to an article by National Library of Medicine, Diclofenac 3% gel is a potential treatment for DSAP, thus growing its adoption.

Side Effects Reported With the Treatment

The side effects of laser treatment include mild erythema, slight hyperpigmentation and modern edema. According to dermentz.org, no treatment has proved effective for long term which grows the hesitation among patients ready for the treatment.

Moreover, high cost of treatment and lack of awareness among people about the skin treatment are other factors that restrain the growth of porokeratosis treatment.

Competitive Landscape

Prominent players in the market include Coherent Inc., Alma Lasers, Almirall, Allergan, Pfizer, Lumenis, Coty Inc., Cutera, Bioness Inc., Biogen, PhotoMedex Inc., Valeant Pharmaceuticals, Hologic Inc., IPG Photonics Corporation, IRIDEX Corp., Hoffman-La Roche Ltd., Biolase Inc., Angiodynamics Inc., Beiersdorf AG, etc.

New Topical Treatment for Actinic Keratosis, tirbanibulin by Almirall got FDA approved in December 2020. Tirbanibulin is a novel microtubule which should be applied once in 5 days. In one of the largest Phase III clinical study programs for a topical Actinic Keratosis lesions, tirbanibulin showed results in 57 days on face and scalp areas in large number of patients.

Hologic, a global leader in Women’s health in January 2021 announced the acquisition of Biotheranostics, Inc. The latter is a commercial stage company providing molecular diagnostic tests for breast and metastatic cancers. The acquisition aims to leverage commercial capabilities, accelerate the growth, deliver more personalised treatment and provide better clinical outcomes for women.  

Regional outlook                                                                  

North America is projected to dominate the market for owing to the rising prevalence of DSAP and rise in renal transplant cases. Increasing kidney transplant cases have also witnessed rise in patients suffering from porokeratosis as per sciencedirect.com. According to niddk.nih.gov, more than 661,000 Americans have kidney failure and more than 468,000 patients are on dialysis, which may affect the porokeratosis cases too as the disease is prevalent in 10% of patients having kidney problems.

Rising health care infrastructure and increase in expenditure spent on health care is contributing Asia toward the market growth. Moreover, geriatric population is high in Japan leading to more cases of the disease in the country. DSAP and Mibelli are more common porokerarosis in Asian region. Lack of awareness among people regarding the treatment is the cause of increase in cases, therefore, government should take initiatives to help people in rural areas know about the treatments which may lead to rise in adopting the treatment.

Europe is at the second position in the porokeratosis market as the rising incidences and innovations by researchers and manufacturers is increasing the market growth. Increasing contribution of manufacturers for the treatment of porokeratosis may grow the market.

Segmentation

Based on Therapies

  • Topical 5- fluorouracil
  • Topical Vitamin D
  • Imiquimod
  • Retinoids
  • Cryotherapy
  • Laser Therapy
  • Others

Based on End-user

  • Hospitals
  • Clinics
  • Diagnostic Centres
  • Research and academic Institutes

Based on Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Key Questions Answered

  • Who are the leading players in the porokeratosis treatment market?

    Biogen, PhotoMedex Inc., Valeant Pharmaceuticals, Hologic Inc., IPG Photonics Corporation, IRIDEX Corp, etc.

  • What are the treatment ways of porokeratosis?

     Excision, cryotherapy, laser, fluorouracil cream, diclofenac gel, vitamin D3, etc.

  • Which age sector is more prone to porokeratosis?

    Mostly people above 50 years of age tend to suffer with the mentioned disease more, but few people of 30-50 years of age are reported having the disease.

  • Which region to hold the largest market for porokeratosis?

    North America to hold the largest share in the market.

  • What are the restraints that may effect the treatment growth?

    High cost of treatment, less awareness regarding porokeratosis and its adverse effects, and fear of side effects among people may hamper the treatment market. 

This study provides a particularized anatomy according to the L.E.A.P mechanism

  • Latest trends and cardinal growth prospects
  • Existing and future insights in growth
  • Ascensions in technology
  • Pain points

The regional analysis offers market assays across:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study, prepared through the L.E.A.P mechanism adds a dimension of infallibility and assures precise information on all the growth dynamics.

Latest Trends and Cardinal Growth Prospects

The study assists in burnishing the knowledge of the stakeholder in terms of the emerging trends. The study provides an expansive coverage on the latest developments and novel profit-yielding sources that augur well with the market. A dedicated and determined team of experts conduct an out-and-out research on diverse aspects to offer ultimate breakthroughs in the market.

Existing and Future Insights in Growth

The interfusion of ubiquitous primary and secondary research through modern tools invites perfection and accuracy in every aspect. Primary research is circumspectly conducted through exhaustive interactions and interviews of experts. These valuable opinions are then neatly inducted in the report to allow the stakeholder for reaping the benefits. A treasure of secondary data is extracted via famed paid sources, yearly estimates and statements, renowned journals, and government documents. These sources assist in creating a robust database comprising existing and subsequent growth dynamics.

Ascensions in Technology

Diverse technological advancements and cutting-edge innovations in the market have been covered in this study to assist the stakeholder in research and development activities. Recent upgrades have also been added in the study, thus helping the stakeholder to paint the strokes of growth on the canvas of the market.

Pain Points

The study presents a plethora of challenges and obstacles that can hinder the growth of the market to allow the stakeholder to prepare their strategies accordingly.

The world ushered in the new decade with the shadow of the COVID-19 pandemic. The outbreak has damaged the growth prospects of several businesses and has crippled the entire economy. The study is in tandem with the changing dynamics of the market due to the SARS-CoV-2 outbreak. The study focuses on the coronavirus pandemic and analyses every aspect that impacts the growth positively or negatively.

An aerial perspective of the regions covered in this study enables the stakeholder to design strategies accordingly. The 360-degree assessment of every aspect associated with growth offers information on a rainbow of growth opportunities available across the market.

The exhaustive study motivates the stakeholder to take the 'LEAP' of faith and achieve success!

This report is the key to questions such as:

What are the prominent factors that will help in reshaping the market growth?

Which trends have the potential to bring expansive growth for the market?

What are the necessary strategies to overcome the ill-effects of the COVID-19 pandemic?

Which regions will emerge as champion growth contributors for the market?

Which aspects will serve as game-changers for the market?

What are the latest innovations in the market?

Which factors will hinder the growth of the market?